Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen (2022)

First Author: Poole A
Attributed to:  Developing better biopharmaceuticals using biomolecular simulation and design funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-32811-1

PubMed Identifier: 36088370

Publication URI: http://europepmc.org/abstract/MED/36088370

Type: Journal Article/Review

Parent Publication: Nature Communications

Issue: 1

ISSN: 2041-1723